Donald L. “Skip” Trump

Donald L. "Skip" Trump, MD

Former chief executive officer and executive director, Inova Schar Cancer Institute

Latest Stories
Book ReviewCancer History ProjectFree
One would get little quarrel with the hypothesis that the development of “targeted therapy” is one of the most substantial advances in cancer care and cancer research over the past 50 years.
FreeGuest EditorialIn the Archives
Letter to the editor by Donald L. “Skip” Trump, MD, and Eric T. Rosenthal, coauthors of Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
When we decided to write a book together about the history and impact of NCI-designated cancer centers since passage of the 1971 National Cancer Act, we both agreed that one of the first people we would interview was Joe Simone.
Oncology pioneer John W. Yarbro, MD, PhD, died April 13 in Miramar Beach, Florida. He was 88.
ClinicalFreeTrials & Tribulations
Despite the many advances in oncology, important problems continue to beset the field, including rapidly rising costs, uneven patterns of care, and poor access to (and participation in) cancer trials. A model that has been recently developed and tested to address these issues is the so-called academic hybrid community cancer center.